Join the Network
Twitter Linkedin

Deprescribing

Is there a Role for Pharmacoepidemiology in Deprescribing Research?

October 12, 2022

October 6, 2022   |  12:00 – 1:00 PM Eastern / 9:00 – 10:00 AM Pacific The session, hosted by the International Society for Pharmacoepidemiology (ISPE), will begin with a brief introduction of the topic and the speakers (moderators, 4-5 min, Drs. Andrew Zullo & Daniela Moga) followed by presentations to address: The existing deprescribing landscape (including existing …

Is there a Role for Pharmacoepidemiology in Deprescribing Research? Read More »

Deprescribing Interventions: Learnings from an Overview of Systematic Reviews

September 14, 2022

https://youtu.be/6g5nHveow1Y Rigorous evidence to guide deprescribing is limited, and priorities to inform deprescribing research and practice remain unclear. Further, it is not known if there are medication targets or patient groups that are most likely to yield the greatest benefit in improving outcomes to inform allocation of limited healthcare resources.   This study, funded as part …

Deprescribing Interventions: Learnings from an Overview of Systematic Reviews Read More »

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial

May 31, 2022

Elizabeth Bayliss, MD, MSPHSenior Investigator, Institute for Health Research, Kaiser Permanente ColoradoProfessor of Family Medicine, University of Colorado School of MedicineIMPACT Health Care Systems (HCS) CoreUSDeN Data and Resources Core Co-LeaderUSDeN Measures Working Group Leader Cynthia Boyd, MD, MPHDirector, Division of Geriatric Medicine and GerontologyProfessor of Medicine, Epidemiology and Health Policy and ManagementJohns Hopkins University …

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial Read More »

Beyond Study Design and Primary Outcomes: Lessons Learned from a Deprescribing Trial to Increase Cognitive Reserve

April 19, 2022

Presenter: Dr. Daniela Moga is an Associate Professor and Larry H. Spears Endowed Chair in Pharmacogenetics in the College of Pharmacy at University of Kentucky. April 12, 2022 | 2PM ET / 11AM PT The course of Alzheimer’s disease (AD) includes a 10–20-year preclinical period with progressive accumulation of amyloid β plaques and neurofibrillary tangles …

Beyond Study Design and Primary Outcomes: Lessons Learned from a Deprescribing Trial to Increase Cognitive Reserve Read More »

Deprescribing and Delirium, Co-hosted by USDeN and NIDUS

January 21, 2022

Presenter: Noll. L. Campbell, PharmD, MS, Assistant Professor of Pharmacy Practice at Purdue University College of Pharmacy Moderator: Sharon K. Inouye, MD, MPH, Professor of Medicine, Director of the Aging Brain Center at the Marcus Institute for Aging Research at Harvard Medical School, Hebrew SeniorLife January 18, 2022 | 2PM ET / 11AM PT Several medications have long …

Deprescribing and Delirium, Co-hosted by USDeN and NIDUS Read More »

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.